Medical Scientists, Except Epidemiologists in Boston-Cambridge-Newton, MA-NH

Employers filed 422 applications covering 422 positions for this role here, at a median of $116,441 a year.

What the government requires here

The prevailing wage for Medical Scientists, Except Epidemiologists in Boston-Cambridge-Newton, MA-NH, wage year 2025-26 — the four levels an employer must meet depending on the experience the role demands.

Level	Who it is for	A year
Level I	Entry: a role needing basic understanding and close supervision	$84,906
Level II	Qualified: some experience, moderate supervision	$106,870
Level III	Experienced: sound understanding, limited supervision	$128,814
Level IV	Fully competent: judgement, may supervise others	$150,779

Who filed, and at what

Employer	Level	Filings	Positions	Median
General Hospital Corporation	Level I	76	76	$71,750
Brigham and Women's Hospital	Level I	34	34	$71,750
General Hospital Corporation	Level II	15	15	$100,000
Vertex Pharmaceuticals Incorporated	Level II	15	15	$106,870
Beth Israel Deaconess Medical Center,Inc.	Level I	14	14	$73,005
Children's Hospital Corporation	Level I	14	14	$75,398
Massachusetts Eye and Ear Infirmary	Level I	12	12	$71,750
Takeda Development Center Americas, Inc.	Level IV	9	9	$168,956
Vertex Pharmaceuticals Incorporated	Level III	7	7	$128,814
Joslin Diabetes Center, Inc.	Level I	5	5	$77,267
Massachusetts Eye and Ear Associates	Level I	5	5	$80,000
Massachusetts Institute of Technology	Level I	5	5	$80,000
Mclean Hospital	Level I	5	5	$71,750
Spaulding Rehabilitation Hospital	Level I	5	5	$75,000
Takeda Development Center Americas, Inc.	Level III	5	5	$163,000
TRUSTEES OF BOSTON UNIVERSITY	Level I	5	5	$80,000
Alnylam US, Inc.	Level III	4	4	$188,000
Brigham and Women's Hospital	Level II	4	4	$116,441
Bristol-Myers Squibb Company	Level III	4	4	$157,363
ClearView Healthcare Partners, LLC	Level II	4	4	$152,500
Harvard University	Level I	4	4	$77,984
Sanofi US Services Inc.	Level II	4	4	$114,560
AstraZeneca Pharmaceuticals LP	Level II	3	3	$179,487
Beth Israel Deaconess Medical Center, Inc.	Level II	3	3	$107,000
Eli Lilly and Company	Level IV	3	3	$169,816
GlaxoSmithKline LLC	Level I	3	3	$147,675
Novartis Institutes for BioMedical Research, Inc.	Level I	3	3	$84,906
Novartis Institutes for BioMedical Research, Inc.	Level II	3	3	$106,870
Takeda Development Center Americas, Inc.	Level II	3	3	$121,412
Vertex Pharmaceuticals Incorporated	Level I	3	3	$84,906
Alexion Pharmaceuticals, Inc.	Level III	2	2	$233,376
Alfresco Ram Inc.	Level IV	2	2	$198,000
Alnylam US, Inc.	Level II	2	2	$142,500
Alnylam US, Inc.	Level IV	2	2	$177,500
Biogen, Inc.	Level IV	2	2	$183,890
Brigham & Women's Faulkner Hospital	Level I	2	2	$78,203
Brigham and Women's Hospital	Level IV	2	2	$134,805
Child Mind Institute, Inc.	Level I	2	2	$84,906
Corixa Corporation	Level I	2	2	$89,925
Corixa Corporation	Level III	2	2	$149,325
Dana-Farber Cancer Institute	Level I	2	2	$74,192
Flagship Pioneering, Inc.	Level I	2	2	$96,000
HARVARD MEDICAL FACULTY PHYSICIANS AT BETH ISRAEL DEACONESS MEDICAL CENTER	Level I	2	2	$420,250
Harvard University	Level II	2	2	$112,590
ModernaTX, Inc.	Level II	2	2	$118,835
Regeneron Pharmaceuticals, Inc.	Level II	2	2	$177,900
Takeda Pharmaceuticals America Inc.	Level I	2	2	$164,480
TRUSTEES OF BOSTON UNIVERSITY	Level II	2	2	$123,456
Tufts Medical Center, Inc.	Level III	2	2	$120,000
UCB BioSciences Inc.	Level II	2	2	$106,870
Zag Bio, Inc.	Level II	2	2	$128,618
AbbVie Bioresearch Center Inc.	Level III	1	1	$130,553
AIRNA Corporation	Level IV	1	1	$190,000
Amgen Inc.	Level III	1	1	$133,000
Anagram Therapeutics, Inc.	Level II	1	1	$110,000
Apellis Pharmaceuticals Inc.	Level III	1	1	$167,215
AstraZeneca Pharmaceuticals LP	Level III	1	1	$250,380
BioNTech US Inc.	Level II	1	1	$107,000
Boston Children's Network Specialty Physicians, Inc	Level I	1	1	$77,265
Brigham & Women's Faulkner Hospital	Level II	1	1	$175,153
Brigham and Women’s Hospital	Level II	1	1	$100,000
Bristol-Myers Squibb Company	Level IV	1	1	$192,436
The Broad Institute, Inc.	Level II	1	1	$128,624
The Broad Institute, Inc.	Level III	1	1	$155,027
Cambridge Public Health Commission	Level I	1	1	$71,406
ClearView Healthcare Partners, LLC	Level I	1	1	$95,000
ClearView Healthcare Partners, LLC	Level III	1	1	$130,000
CRISPR Therapeutics, Inc.	Level II	1	1	$124,919
Dash Bio, Inc.	Level II	1	1	$107,000
Edgewise Therapeutics, Inc.	Level II	1	1	$225,000
EMD Serono Research and Development Institute, Inc.	Level IV	1	1	$200,000
Foundation Medicine, Inc.	Level II	1	1	$106,870
General Hospital Corporation	Level IV	1	1	$178,606
Genzyme Corporation	Level I	1	1	$100,500
Genzyme Corporation	Level IV	1	1	$150,779
Giner, Inc.	Level I	1	1	$84,906
GlaxoSmithKline LLC	Level II	1	1	$130,000
Harvard Pilgrim Health Care Institute, LLC	Level I	1	1	$72,000
Ingenia Therapeutics Inc.	Level II	1	1	$107,000
INIA Biosciences, Inc.	Level I	1	1	$95,992
Janssen Research & Development, LLC	Level II	1	1	$194,100
Koroid Corporation	Level III	1	1	$160,000
LONZA HOUSTON INC	Level III	1	1	$130,000
LYNXKITE INC.	Level II	1	1	$144,000
Massachusetts General Physicians Organization	Level II	1	1	$110,000
Moderna Services, Inc.	Level IV	1	1	$175,000
ModernaTX, Inc.	Level I	1	1	$88,100
Montai Therapeutics, Inc.	Level II	1	1	$110,000
Northeastern University	Level I	1	1	$71,406
Obsidian Therapeutics, Inc.	Level II	1	1	$110,000
Ocular Therapeutix, Inc.	Level I	1	1	$104,000
PFIZER INC.	Level III	1	1	$143,276
PFIZER INC.	Level IV	1	1	$161,100
PPD Development, L.P.	Level III	1	1	$128,814
Ring Therapeutics, Inc.	Level II	1	1	$108,861
Sail Biomedicines, Inc.	Level II	1	1	$110,000
Sanegene Bio USA Inc.	Level II	1	1	$127,000
Sanofi Vaccines US Inc.	Level I	1	1	$100,500
Sanofi Vaccines US Inc.	Level III	1	1	$128,814
Sarepta Therapeutics, Inc.	Level II	1	1	$131,000

Tell me when this moves

One email when the prevailing wage for Medical Scientists, Except Epidemiologists in Boston-Cambridge-Newton, MA-NH changes — the library turns over every July, and what an employer must offer changes with it.

Source: OFLC disclosure data and prevailing wage library, US Department of Labor (public domain). Figures are what employers filed, not what they paid.